Wells Fargo
AMED

Wells Fargo’s Amedisys AMED Stock Holding History

Wells Fargo’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,433
Closed -$436K – 7076
2025
Q2 		$436K Sell
4,433
-1,498
-25% -$142K ﹤0.01% 4244
2025
Q1 		$549K Sell
5,931
-1,230
-17% -$113K ﹤0.01% 4028
2024
Q4 		$650K Buy
7,161
+323
+5% +$29.7K ﹤0.01% 4003
2024
Q3 		$660K Sell
6,838
-1,476
-18% -$144K ﹤0.01% 3819
2024
Q2 		$763K Sell
8,314
-24,867
-75% -$2.31M ﹤0.01% 3666
2024
Q1 		$3.06M Buy
33,181
+2,078
+7% +$195K ﹤0.01% 2635
2023
Q4 		$2.96M Sell
31,103
-997
-3% -$93.1K ﹤0.01% 2597
2023
Q3 		$3M Sell
32,100
-1,892
-6% -$175K ﹤0.01% 2478
2023
Q2 		$3.11M Buy
33,992
+1,849
+6% +$152K ﹤0.01% 2536
2023
Q1 		$2.36M Sell
32,143
-1,121
-3% -$97K ﹤0.01% 2727
2022
Q4 		$2.78M Sell
33,264
-13,889
-29% -$1.25M ﹤0.01% 2523
2022
Q3 		$4.56M Sell
47,153
-8,773
-16% -$1.05M ﹤0.01% 2065
2022
Q2 		$5.88M Sell
55,926
-87,338
-61% -$11.2M ﹤0.01% 1969
2022
Q1 		$24.7M Buy
143,264
+2,880
+2% +$430K 0.01% 1169
2021
Q4 		$22.7M Sell
140,384
-265,301
-65% -$42.6M 0.01% 1246
2021
Q3 		$60.5M Sell
405,685
-33,649
-8% -$6.99M 0.01% 942
2021
Q2 		$108M Sell
439,334
-190,253
-30% -$49.9M 0.02% 641
2021
Q1 		$167M Sell
629,587
-13,109
-2% -$3.7M 0.04% 453
2020
Q4 		$189M Buy
642,696
+9,850
+2% +$2.53M 0.05% 403
2020
Q3 		$150M Buy
632,846
+7,870
+1% +$1.79M 0.04% 412
2020
Q2 		$124M Buy
624,976
+11,195
+2% +$2.09M 0.04% 454
2020
Q1 		$113M Sell
613,781
-14,639
-2% -$2.6M 0.04% 430
2019
Q4 		$105M Buy
628,420
+329,063
+110% +$48.9M 0.03% 560
2019
Q3 		$39.2M Sell
299,357
-7,549
-2% -$983K 0.01% 1045
2019
Q2 		$37.3M Buy
306,906
+2,393
+0.8% +$284K 0.01% 1087
2019
Q1 		$37.5M Buy
304,513
+19,554
+7% +$2.45M 0.01% 1062
2018
Q4 		$33.4M Sell
284,959
-282,379
-50% -$33.3M 0.01% 1048
2018
Q3 		$70.9M Sell
567,338
-403,432
-42% -$44.6M 0.02% 737
2018
Q2 		$83M Sell
970,770
-186,210
-16% -$13.7M 0.02% 654
2018
Q1 		$69.8M Buy
1,156,980
+71,772
+7% +$4.09M 0.02% 740
2017
Q4 		$57.2M Sell
1,085,208
-398,833
-27% -$21M 0.02% 812
2017
Q3 		$83M Buy
1,484,041
+339,825
+30% +$18M 0.03% 625
2017
Q2 		$71.9M Sell
1,144,216
-349,862
-23% -$20.4M 0.02% 690
2017
Q1 		$76.3M Sell
1,494,078
-239,498
-14% -$11.4M 0.02% 652
2016
Q4 		$73.9M Buy
1,733,576
+2,612
+0.2% +$111K 0.03% 640
2016
Q3 		$82.1M Buy
1,730,964
+53,652
+3% +$2.68M 0.03% 577
2016
Q2 		$84.7M Buy
1,677,312
+1,567,227
+1,424% +$79.1M 0.03% 534
2016
Q1 		$5.32M Buy
110,085
+96,466
+708% +$3.72M ﹤0.01% 2265
2015
Q4 		$536K Buy
13,619
+3,475
+34% +$139K ﹤0.01% 3883
2015
Q3 		$385K Sell
10,144
-1,647
-14% -$69.5K ﹤0.01% 4109
2015
Q2 		$469K Buy
11,791
+6,973
+145% +$217K ﹤0.01% 4137
2015
Q1 		$129K Sell
4,818
-92,424
-95% -$2.61M ﹤0.01% 4636
2014
Q4 		$2.85M Sell
97,242
-40,281
-29% -$995K ﹤0.01% 2761
2014
Q3 		$2.77M Sell
137,523
-21,622
-14% -$417K ﹤0.01% 2787
2014
Q2 		$2.66M Sell
159,145
-826,594
-84% -$11.7M ﹤0.01% 2817
2014
Q1 		$14.7M Sell
985,739
-223,376
-18% -$3.44M 0.01% 1487
2013
Q4 		$17.7M Sell
1,209,115
-257,945
-18% -$4.15M 0.01% 1308
2013
Q3 		$25.2M Sell
1,467,060
-242,116
-14% -$3.59M 0.01% 1051
2013
Q2 		$19.8M Buy
+1,709,176
New +$19.6M 0.01% 1156

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wells Fargo's AMED Position: Q3 2025 in Review

Wells Fargo sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,433 shares — an estimated $436K sold.

Wells Fargo first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $189M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Wells Fargo reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 4,433 Amedisys shares in Q3 2025, an estimated $436K.
  • Wells Fargo first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Wells Fargo's Amedisys position peaked at $189M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.